235 related articles for article (PubMed ID: 36147506)
1. A novel immune-related radioresistant lncRNAs signature based model for risk stratification and prognosis prediction in esophageal squamous cell carcinoma.
Zheng J; Chen X; Huang B; Li J
Front Genet; 2022; 13():921902. PubMed ID: 36147506
[No Abstract] [Full Text] [Related]
2. Novel chemokine related LncRNA signature correlates with the prognosis, immune landscape, and therapeutic sensitivity of esophageal squamous cell cancer.
Zhang Z; Wang J; Han W; Zhao L
BMC Gastroenterol; 2023 Apr; 23(1):132. PubMed ID: 37081402
[TBL] [Abstract][Full Text] [Related]
3. The prognostic value of a seven-lncRNA signature in patients with esophageal squamous cell carcinoma: a lncRNA expression analysis.
Weng NQ; Chi J; Wen J; Mai SJ; Zhang MY; Huang L; Liu J; Yang XZ; Xu GL; Fu JH; Wang HY
J Transl Med; 2020 Jan; 18(1):47. PubMed ID: 32005248
[TBL] [Abstract][Full Text] [Related]
4. Identification of m
Ma Y; Sun Y; Zhao X; Li J; Fu X; Gong T; Zhang X
Sci Rep; 2023 Sep; 13(1):14499. PubMed ID: 37666951
[TBL] [Abstract][Full Text] [Related]
5. A three-lncRNA signature predicts overall survival and disease-free survival in patients with esophageal squamous cell carcinoma.
Huang GW; Xue YJ; Wu ZY; Xu XE; Wu JY; Cao HH; Zhu Y; He JZ; Li CQ; Li EM; Xu LY
BMC Cancer; 2018 Feb; 18(1):147. PubMed ID: 29409459
[TBL] [Abstract][Full Text] [Related]
6. Identification of a nomogram based on long non-coding RNA to improve prognosis prediction of esophageal squamous cell carcinoma.
Li W; Liu J; Zhao H
Aging (Albany NY); 2020 Jan; 12(2):1512-1526. PubMed ID: 31978896
[TBL] [Abstract][Full Text] [Related]
7. Exploring the Potential of Exosome-Related LncRNA Pairs as Predictors for Immune Microenvironment, Survival Outcome, and Microbiotain Landscape in Esophageal Squamous Cell Carcinoma.
Zhao F; Li Z; Dong Z; Wang Z; Guo P; Zhang D; Li S
Front Immunol; 2022; 13():918154. PubMed ID: 35880180
[TBL] [Abstract][Full Text] [Related]
8. A Novel Autophagy-Related Long Non-Coding RNA Signature to Predict Prognosis and Therapeutic Response in Esophageal Squamous Cell Carcinoma.
Shi X; Liu X; Pan S; Ke Y; Li Y; Guo W; Wang Y; Ruan Q; Zhang X; Ma H
Int J Gen Med; 2021; 14():8325-8339. PubMed ID: 34815705
[TBL] [Abstract][Full Text] [Related]
9. Bioinformatics identification of lncRNA biomarkers associated with the progression of esophageal squamous cell carcinoma.
Yu J; Wu X; Huang K; Zhu M; Zhang X; Zhang Y; Chen S; Xu X; Zhang Q
Mol Med Rep; 2019 Jun; 19(6):5309-5320. PubMed ID: 31059058
[TBL] [Abstract][Full Text] [Related]
10. Identification of Epithelial-Mesenchymal Transition- (EMT-) Related LncRNA for Prognostic Prediction and Risk Stratification in Esophageal Squamous Cell Carcinoma.
Wang P; Chen Y; Zheng Y; Fu Y; Ding Z
Dis Markers; 2021; 2021():5340240. PubMed ID: 34712369
[TBL] [Abstract][Full Text] [Related]
11. Identification and validation of an eight-lncRNA signature that predicts prognosis in patients with esophageal squamous cell carcinoma.
Zhang J; Ling X; Fang C; Ma J
Cell Mol Biol Lett; 2022 May; 27(1):39. PubMed ID: 35578166
[TBL] [Abstract][Full Text] [Related]
12. Construction of the Six-lncRNA Prognosis Signature as a Novel Biomarker in Esophageal Squamous Cell Carcinoma.
Zheng ZJ; Li YS; Zhu JD; Zou HY; Fang WK; Cui YY; Xie JJ
Front Genet; 2022; 13():839589. PubMed ID: 35432441
[TBL] [Abstract][Full Text] [Related]
13. Identification and validation of an autophagy-related gene signature for predicting prognosis in patients with esophageal squamous cell carcinoma.
Shi X; Li Y; Pan S; Liu X; Ke Y; Guo W; Wang Y; Ruan Q; Zhang X; Ma H
Sci Rep; 2022 Feb; 12(1):1960. PubMed ID: 35121801
[TBL] [Abstract][Full Text] [Related]
14. Excavating novel diagnostic and prognostic long non-coding RNAs (lncRNAs) for head and neck squamous cell carcinoma: an integrated bioinformatics analysis of competing endogenous RNAs (ceRNAs) and gene co-expression networks.
Yang L; Lu P; Yang X; Li K; Chen X; Qu S
Bioengineered; 2021 Dec; 12(2):12821-12838. PubMed ID: 34898376
[TBL] [Abstract][Full Text] [Related]
15. The Prognostic Significance of Metabolic Syndrome and a Related Six-lncRNA Signature in Esophageal Squamous Cell Carcinoma.
Liu Y; Wang L; Liu H; Li C; He J
Front Oncol; 2020; 10():61. PubMed ID: 32133283
[No Abstract] [Full Text] [Related]
16. Prognostic value of a five-lncRNA signature in esophageal squamous cell carcinoma.
Zhang L; Li P; Liu E; Xing C; Zhu D; Zhang J; Wang W; Jiang G
Cancer Cell Int; 2020; 20():386. PubMed ID: 32831646
[TBL] [Abstract][Full Text] [Related]
17. Development and Validation of a Prognostic Gene Signature Correlated With M2 Macrophage Infiltration in Esophageal Squamous Cell Carcinoma.
Yao J; Duan L; Huang X; Liu J; Fan X; Xiao Z; Yan R; Liu H; An G; Hu B; Ge Y
Front Oncol; 2021; 11():769727. PubMed ID: 34926275
[TBL] [Abstract][Full Text] [Related]
18. Genome-wide analysis of lncRNAs, miRNAs, and mRNAs forming a prognostic scoring system in esophageal squamous cell carcinoma.
Shi X; Li Y; Sun Y; Zhao X; Sun X; Gong T; Liang Z; Ma Y; Zhang X
PeerJ; 2020; 8():e8368. PubMed ID: 32095316
[TBL] [Abstract][Full Text] [Related]
19. Transcriptome profiling of lncRNA and co-expression networks in esophageal squamous cell carcinoma by RNA sequencing.
Li Y; Shi X; Yang W; Lu Z; Wang P; Chen Z; He J
Tumour Biol; 2016 Oct; 37(10):13091-13100. PubMed ID: 27449043
[TBL] [Abstract][Full Text] [Related]
20. Development and Validation of the Oxidative Stress Related lncRNAs for Prognosis in Esophageal Squamous Cell Carcinoma.
Zheng X; Liu W; Zhu Y; Kong W; Su X; Huang L; Cui Y; Sun G
Cancers (Basel); 2023 Sep; 15(17):. PubMed ID: 37686677
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
